Get real time updates directly on you device, subscribe now.
IMARC Group’s report titled “Anti-Snoring Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global anti-snoring treatment market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.
Snoring refers to a noisy breathing sound coming through the nose or mouth of an individual, which is caused by the vibration of the soft tissues of the throat. It is medically treated using surgery or continuous positive airway pressure (CPAP), wherein a mask is worn over the nose or mouth and attached to a machine to deliver a constant flow of air into the nostrils. Snoring can also be cured via lifestyle changes, including maintaining body weight, relieving nasal obstruction, changing sleep positions, and avoiding alcohol and sedating medications.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/anti-snoring-treatment-market/requestsample
Anti-Snoring Treatment Market Trends and Drivers:
The increasing technological advancements in devices that support this therapy are primarily driving the anti-snoring treatment market. Furthermore, the rising risk of long-term effects of this noisy breathing, such as fatigue, heart attacks, hypertension, stroke, type 2 diabetes, and decreased blood oxygen levels, is also augmenting the market growth. Apart from this, the escalating demand for this treatment solution as loud and frequent snoring is one of the signs of obstructive sleep apnea (OSA) that can lead to cancer, glaucoma, cognitive and behavioral disorders, and road accidents is positively influencing the global market. Moreover, the widespread adoption of anti-snoring apps, behavioral therapies, dental devices, tongue stabilizing devices (TSD), and mandibular advancing devices (MAD), also known as jaw advancing devices (JAD), for a noisy breathing treatment, which is further bolstering the market growth. Besides this, sedentary lifestyles and unhealthy dietary habits are acting as significant growth-inducing factors. Additionally, the increasing tobacco and alcohol consumption and the growing prevalence of sleep disorders among the population are expected to drive the anti-snoring treatment market in the coming years.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Device Type:
- Mandibular Advancement Devices (MAD)
- Tongue Stabilizing Devices (TSD)
- Continuous Positive Airway Pressure (CPAP) Devices
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Airway Management Inc.
- Apnea Sciences Corporation
- Fisher & Paykel Healthcare Corporation Limited
- Koninklijke Philips N.V.
- MEDiTAS Ltd.
- Medtronic plc
- Mitsui Chemicals Inc.
- ResMed Inc.
- Rotech Healthcare Inc.
- SomnoMed
- The Pure Sleep Company and Tomed GmbH
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
Comments are closed.